Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lisabeth, L. D.
Right arrow Articles by Levine, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lisabeth, L. D.
Right arrow Articles by Levine, S. R.
Related Collections
Right arrow All Health Services Research
Right arrow All Cerebrovascular disease/Stroke
Right arrow Risk factors in epidemiology
Right arrow Infarction
NEUROLOGY 2004;62:2313-2315
© 2004 American Academy of Neurology
Brief Communications

Do gender and race impact the use of antithrombotic therapy in patients with stroke/TIA?

Lynda D. Lisabeth, PhD, Canopy Roychoudhury, PhD, Devin L. Brown, MD and Steven R. Levine, MD

From the Stroke Program (Drs. Lisabeth and Brown), University of Michigan Health System, Ann Arbor; Michigan Peer Review Organization (MPRO) (Dr. Roychoudhury), Farmington Hills; and Stroke Program (Dr. Levine), Mount Sinai School of Medicine, New York, NY.

Address correspondence and reprint requests to Dr. Lynda Lisabeth, NI3D19–300 North Ingalls, University of Michigan, Ann Arbor, MI 48109–0489; e-mail: llisabet{at}umich.edu

The authors examined the relationships between sex and race and antithrombotics prescribed at discharge in the Michigan Medicare population using retrospective medical record abstraction (n = 2,715) for the period January 1, 2001, to June 30, 2001. There were no differences in the use of antithrombotics at discharge by race or sex and no differences in the prescribing of aspirin, warfarin, aspirin/extended release dipyridamole, or clopidogrel by race or sex after adjustment for confounders.

Received November 26, 2003. Accepted in final form February 10, 2004.




This article has been cited by other articles:


Home page
 StrokeHome page
M. J. Reeves, G. C. Fonarow, X. Zhao, E. E. Smith, L. H. Schwamm, and on behalf of the GWTG-Stroke Steering Committee &
Quality of Care in Women With Ischemic Stroke in the GWTG Program
Stroke, April 1, 2009; 40(4): 1127 - 1133.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
D. Kleindorfer
Sociodemographic Groups at Risk: Race/Ethnicity
Stroke, March 1, 2009; 40(3_suppl_1): S75 - S78.
[Full Text] [PDF]

Home page
 NeurologyHome page
B. S. Jacobs, G. Birbeck, A. J. Mullard, S. Hickenbottom, R. Kothari, S. Roberts, and M. J. Reeves
Quality of hospital care in African American and white patients with ischemic stroke and TIA
Neurology, March 28, 2006; 66(6): 809 - 814.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
D. L. Brown, L. D. Lisabeth, C. Roychoudhury, Y. Ye, and L. B. Morgenstern
Recurrent Stroke Risk Is Higher Than Cardiac Event Risk After Initial Stroke/Transient Ischemic Attack
Stroke, June 1, 2005; 36(6): 1285 - 1287.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.